Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Functional Foods"
DOI: 10.1016/j.jff.2021.104459
Abstract: Abstract Background Low-carbohydrate diets, including the modified Atkins diet (mAD), are commonly used to promote weight loss, improve exercise performance, and treat refractory epilepsy and inherited metabolism disorders. However, the effects of the high-fat-low-carbohydrate diet…
read more here.
Keywords:
atkins diet;
hyperventilation;
cardiopulmonary exercise;
modified atkins ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "PharmaNutrition"
DOI: 10.1016/j.phanu.2019.100154
Abstract: Abstract Background Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the fourth cause of end stage renal disease (ESRD) and urgently requires the development of effective therapeutic treatments. The presence of a shift in energy metabolism…
read more here.
Keywords:
diet adpkd;
atkins diet;
adpkd patients;
pilot study ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of Child Neurology"
DOI: 10.1177/08830738211004747
Abstract: Objectives: We aimed to evaluate the efficacy of the modified Atkins diet in children with epileptic spasms who had failed hormonal therapy. Methods: Children aged 9 months to 3 years having daily epileptic spasms despite…
read more here.
Keywords:
epileptic spasms;
group;
hormonal therapy;
modified atkins ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Nutricion hospitalaria"
DOI: 10.20960/nh.03172
Abstract: BACKGROUND the ketogenic diet (CD) is an established, effective non-pharmacological treatment for refractory epilepsy in childhood. AIM the objective of this study was to compare the efficacy, the presence of undesirable effects, and adherence between…
read more here.
Keywords:
atkins diet;
refractory epilepsy;
treatment;
ketogenic diet ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Nutrients"
DOI: 10.3390/nu13030840
Abstract: Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is caused by mutations in the SLC2A1 gene and produces seizures, neurodevelopmental impairment, and movement disorders. Ketogenic dietary therapies (KDT) are the gold standard treatment. Similar symptoms…
read more here.
Keywords:
positive negative;
negative patients;
slc2a1 positive;
deficiency syndrome ... See more keywords